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Analysis of peritoneal macrophages in continuous ambulatory dialysis
patients. Peritoneal macrophages (PMC) from patients undergoing
continuous ambulatory pentoneal dialysis (CAPD) were compared to
pentoneal macrophages from healthy volunteers and to peripheral
blood monocytes (PBM) from CAPD patients, hemodialysis patients,
and healthy volunteers. PMC from CAPD patients had morphology
similar to PMC and PBM from healthy volunteers. HLA-DR antigen
and Fc receptors were present on the cell surface. These monocytes
had similar sequential morphologic changes in long-term culture com-
pared to PBM from healthy volunteers. Phagocytosis, hydrogen perox-
ide generation and bactericidal activity were the same in PMC from
CAPD patients as in PBM from healthy volunteers. Chemotaxis and
eicosanoid precursor uptake studies suggest that PMC from CAPD
patients may be relatively immature bone-marrow-derived cells. Al-
though these cells function well as phagocytes, further study is war-
ranted to define their immune competence, many components of which
develop during differentiation into mature macrophages and may there-
fore be deficient in patients undergoing CAPD.
Analyse des macrophages péritonéaux chez des malacles en dialyse
péritoneale continue ambulatoire. Des macrophages péritonéaux (PMC)
provenant de malades en dialyse péritonéale continue ambulatoire(CAPD) ont été compares a des macrophages pCritonéaux de
volontaires sains et a des monocytes sanguins périphériques (PBM)
provenant de malades en CAPD, d'hémodialysCs, et de volontaires
sains. Les PMC provenant des malades en CAPD avaient une
morphologie identique aux PMC et aux PBM des volontaires sains.
L'antigene HLA-DR et les récepteurs Fc étaient presents a Ia surface
cellulaire. Ces monocytes subissaient les mémes changements
morphologiques séquentiels en culture a long terme que les PBM des
volontaires sains. La phagocytose, Ia génération de peroxyde
d'hydrogene et l'activité bactericide étaient les mCmes pour les PMC de
malades en CAPD que pour les PBM des volontaires sains. Des etudes
de chémotaxie et de captation du précurseur des eicosanoides suggerent
que les PMC des malades en CAPD pourraient être des cellules
relativement immatures dérivées de Ia moelle osseuse. Quoique ces
cellules fonctionnent bien en tant que phagocytes, une étude
supplémentaire est nécessaire pour définir leur competence im-
munitaire, dont plusieurs constituants se développent pendant la
différenciation en macrophages matures, et pourraient donc être
déficients chez les malades en CAPD.
Renal replacement therapy for endstage renal disease has
developed rapidly during the last decade with increasing num-
bers of patients utilizing home peritoneal dialysis [continuous
ambulatory peritoneal dialysis (CAPD)]. Peritoneal infection
remains a frequent complication of this procedure [1]. Infection
not only compromises dialytic efficiency, but also has sig-
nificant morbidity, may lead to peritoneal fibrosis [2] and will
subvert the effectiveness of this therapy for the frequently
infected patient.
The possible contribution of peritoneal host defense in the
development of clinical peritonitis during dialysis was first
considered following the observation that transcolonic migra-
tion of bacteria into the peritoneum of anephric dogs occurred
during peritoneal irrigation. In some animals, a local leukocytic
response was associated with abrogation of peritonitis [3]. Hau,
Arenholz, and Simmons [4] studied clearance pathways of
bacteria from the rodent peritoneal cavity and showed that
erythrocyte debris and fibrin strands impair bacterial clearance
from the peritoneum, thereby promoting the development of
clinical peritonitis. Interference with phagocyte function ap-
pears to account for the defect. These observations underscore
the importance of peritoneal leukocytes in protection against
infection.
The mononuclear phagocyte is the predominant cell type
found in peritoneal fluid from healthy noninfected horses [5]
and rodents [6]. Mononuclear cells are also the predominant
cell type in peritoneal dialysate from uninfected patients under-
going acute or chronic peritoneal dialysis [7—11]. Monocytes
and macrophages have also been identified in peritoneal fluid
from normal and infertile women. Cells from patients with
endometriosis contain higher amounts of acid phosphatase and
neutral protease and show greater sperm phagocytosis, suggest-
ing functional activation [12—15]. These observations further
support a role for peritoneal mononuclear phagocytes as an
important first-line defense in patients undergoing CAPD.
Although many aspects of peripheral blood leukocyte func-
tion are intact in azotemic and hemodialysis patients [16, 17],
there is little information regarding this subject in the CAPD
patient population. Specifically, the function of mononuclear
phagocytes has not been investigated.
In the present study, we characterized peritoneal macro-
phages from CAPD patients and compared them to peripheral
blood monocytes from the same patients and stable
hemodialysis patients and to peritoneal macrophages and pe-
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Table 1. Continuous ambulatory peritoneal dialysis study population
Number of Percent of
Demographic variable patients patients
Sex Male 22 60
Female 15 40
Age, years 15—25 2 5
26—35 3 8
36—45 6 16
46—55 13 35
56—65 9 24
66—75 4 12
Diagnosis
Chronic interstitial nephritis 6 16
Chronic glomerulonephntis 5 14
Membranoproliferative GN 2 5
Mesangioproliferative GN 1 3
Lupus nephritis 3 8
Diabetic nephropathy 4 12
Rapidly progressive GN 2 5
Hereditary nephritis 1 3
Polycystic kidney disease 1 3
Focal glomerulosclerosis 2 5
Obstructive nephropathy 1 3
Unknown 9 23
ripheral blood monocytes from healthy control subjects. Com-
parisons were made with respect to the state of activation,
morphology, certain cell surface markers, and metabolic,
phagocytic, chemotactic, and bactericidal activity.
Methods
Patient section
We studied mononuclear phagocytic cells from 37 patients
undergoing CAPD, nearly equally distributed by sex, ranging
from 16 to 75 years of age. Patients with glomerular,
tubulointerstitial, and urological disease were included (Table
1). All patients were studied when uninfected, and no patient
was studied within 30 days of an episode of peritonitis.
Hemodialysis patients were selected at random from a popula-
tion of 87 stable patients on chronic hemodialysis. No patient
was clinically infected at the time of study nor for 1 month
previously.
Healthy volunteers were selected from among women under-
going elective laparoscopy for diagnostic evaluation of infertil-
ity or for tubal ligation. This protocol was approved by the
Committee for Studies Involving Human Beings at the Uni-
versity of Pennsylvania. Patients with severe endometriosis or
extensive pelvic fibrosis were excluded due to recognized
macrophage abnormalities 1131.
Cell preparation
Peripheral blood monocytes were prepared by the method of
Ackerman and Douglas [181. Blood mononuclear cells were
separated by centrifugation over Ficoll-Paque (Pharmacia,
Piscataway, New Jersey). The interphase layer was diluted with
Hank's buffered salt solution (HBSS) with 20% horse serum
(HS) and introduced into tissue culture flasks in which baby
hamster kidney fibroblasts (BHK-2l, clone 13, American type
culture collection) had been grown to confluence and removed.
Nonadherent cells were decanted after 45 mm and the flasks
were rinsed once with warm HBSS. Adherent mononuclear
cells were released by introducing a mixture of HBSS with 20%
HS and phosphate-buffered saline (PBS) containing 10 mM
EDTA. Cells were then washed twice in HBSS with 20% HS
and resuspended in appropriate media at varying cell concentra-
tions as needed for particular experiments. Peripheral blood
monocytes for eicosanoid precursor uptake studies were pre-
pared in a similar fashion, except that tissue culture flasks were
precoated with type 0 human serum instead of BHK-21
microexudate. We have compared several methods of flask
preparation (unpublished observations) and have observed that
monocytes obtained from flasks primed with BHK-2l or type 0
human serum have similar biochemical and functional proper-
ties. Peripheral blood granulocytes were recovered from the
buffy coat of Ficoll-Paque centrifuged blood specimens. Con-
taminating erythrocytes were removed by hypotonic lysis.
Peritoneal macrophages were obtained from CAPD patients
by centrifugation (x 150g, 20 mm) of the complete dialysate
effluent volume (1.5 to 3.5 liters) from an overnight exchange of
at least 4 hr duration. Cells were washed twice in HBSS with
20% HS and resuspended at a concentration of 1 x 106 cells per
ml. Peritoneal macrophages from healthy volunteers were ob-
tained immediately following placement of the laparoscope and
prior to any surgical manipulations. Peritoneal fluid was aspi-
rated by gentle manual suction under direct visual control from
the cul-de-sac and anterior uterovesical compartment. The
cell-rich fluid (10 to 15 ml) was processed in the same fashion as
the peritoneal cells from CAPD patients. Contaminating eryth-
rocytes were removed by hypotonic lysis. All cells were
counted in Neubauer chambers and viability was determined by
trypan blue exclusion. Protein measurements of dialysis su-
pernatants and cell lysates were performed by the method of
Lowry et a! [19].
Cell morphology
Differential cell counts were determined from cytocentrifuge
preparations stained with Duff-Quick (Harleco, Gibbstown,
New Jersey). Nonspecific esterase staining was performed by
the method of Yam, Li, and Crosby [20]. Electron microscopy
was performed on cells fixed in 1.5% glutaraldehyde in 0.1 M
sodium cacodylate and postfixed in 1.0% buffered osmium
tetroxide. The preparations were stained en bloc with 1.0%
uranyl acetate, rapidly dehydrated, and embedded in Epon.
Thin sections, prepared by LKB Ultratome III, were doubly
stained with uranyl acetate and lead citrate and examined in a
Siemens 102 electron microscope.
Erythrocyte rosette assay (EA)
Mononuclear cell immunoglobulin Fc receptors were demon-
strated by rosette formation with IgG (anti-D) coated human
erythrocytes using standard methods [211. Rosettes with three
or more erythrocytes per mononuclear cell were considered
positive. Erythrocyte phagocytosis was demonstrated by ex-
tending the erythrocyte/antibody-mononuclear cell incubation
beyond 2 hr.
Demonstration of HLA-DR antigen
Membrane DR antigen was assayed by the method of Blu-
menthal et al 1221, using cells fixed on coverslips with 1%
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paraformaldehyde whose Fc receptors were bound by equili-
bration with 0.05% rabbit serum. A 1:80 dilution of antihuman
HLA-DR antibody (Becton-Dickinson, Mountain View, Cali-
fornia) was used, and cells were stained with a 1:30 dilution of
fluorescein conjugated goat antimouse IgG. Two hundred cells
were counted and scored positive for HLA-DR if a sharp
peripheral cell fluorescence was observed.
Monocyte culture techniques
Suspension cultures (24 to 48 hr) were prepared by diluting 2
to 4 x 106 mononuclear cells in 40 ml Dulbecco's minimal
essential medium with 10% heat inactivated horse serum and
10% heat-inactivated fetal calf serum (DME 10/10) in 50 ml
conical polypropylene tubes which were placed on a mechani-
cal rotator in a humidified, 5% CO2 incubator at 37°C.
Monolayer cultures (2 to 31 days) were prepared according to
the method of Zuckerman, Ackerman, and Douglas [23].
Briefly, monocytes were prepared as described above and
resuspended in DME 10/10, including 4 mM glutamine, non-
essential amino acids, penicillin and streptomycin at a cell
density of 2.0 to 5.0 x l0 cells per ml per 15 mm tissue culture
well. Cells were placed in a humidified 5% CO2 incubator at
37°C. Medium was changed every 3 days. Growth and develop-
ment in culture was monitored by examination under phase
contrast microscopy using a Zeiss inverted microscope.
Eco-5 '-nucleotidase
Mononuclear cell suspensions or monolayer cultures were
washed once in ice-cold PBS and lysed with freshly prepared
0.05% Triton X-l00 at 4°C. Enzyme activity was measured
according to the method of Edelson and Cohn [24]. Results are
expressed as nanometers of 5'AMP hydrolyzed per minute per
milligram of cell protein.
Hydrogen peroxide generation
Hydrogen peroxide generation in response to stimulation
with phorbol myristate acetate (PMA, P8 139, Sigma Chemical
Company, St. Louis, Missouri) was assayed by measuring the
extinction of fluorescence of scopoletin (7-OH-6-meth-
oxycoumarin), using a modification of the technique of Root et
al [251. PMA was added in a concentration of 0.1 Lg/ml
(100 nM) which, in our system and in others [26], induces
maximum mononuclear phagocyte stimulation. Scopoletin fluo-
rescence was measured on an Aminco-Bowman dual channel
spectrofluorophotometer with an excitation wavelength of 350
nm and an emission wavelength of 430 nm. Hydrogen peroxide
generation was derived from comparison to a standard curve and
is expressed as nanometers of hydrogen peroxide produced per
106 cells per 10 mm, with and without PMA stimulation.
Bactericidal activity
Bactericidal activity was tested by a standard method [27]
using suspensions of Staphylococcus aureus (ATCC 27217) and
Escherichia coli (Seattle) which were washed twice with 0.1%
gelatin in water immediately preceding each assay. Bacterial
concentrations were optimally adjusted spectrophoto-
metrically. Pooled normal human serum, freshly prepared for
each assay, served as an opsonin source. At the time of
inoculation and every 30 mm for 90 mm, an aliquot was plated
on blood agar and incubated at 37°C overnight. Colony counts
were performed the following day and these data extrapolated
to express the percent of bacterial inoculum killed.
Chemotaxis
Chemotaxis was performed in a 48-well chemotaxis chamber
as previously described by Falk, Goodwin, and Leonard [28].
Bottom wells were filled with 25 l of N-formylmethionyl-
leucyl-phenylalanine (FMLP) diluted in HBSS from 10 6M to
10-8 M. A filter sheet (Nucleopore Inc., Cabin John, Mary-
land), polyvinylpyrrolidone-coated, 10 m thick, 5 m hole size
was placed over the wells. Gasket and top plate were assembled
and the apparatus warmed to 37°C. Mononuclear cells, adjusted
to 20,000 cells in 50 jl HBSS with 20% HS were added to each
top well and the chambers were incubated in moist air at 37°C
for 1 hr. After incubation, chambers were disassembled and
filters were removed. Cells remaining on the top side were
wiped off and the filter was air-dried, fixed in methanol, and
stained in Diff-Quick (Harleco, Gibbstown, New Jersey). The
number of cells per 0.625 mm2 area was counted manually using
a scored eyepiece. Twenty areas were counted for each well,
and the average used to determine the number of migrating cells
in the total available area (8 mm2). Random migration was
determined in each experiment by cell movement in response to
HBSS without FMLP, and this value was subtracted from the
chemotaxis scores. The net values are expressed as the percent-
age of cells migrating through the filter as a function of the
number of cells originally loaded in the top chamber.
Cellular uptake of fatty acids
Eicosanoid precursor uptake was measured at the end of a
5-day culture period. Preliminary experiments performed at 3,
5, 7, and 12 days demonstrated consistent differences among
cohorts at all time points beyond the 3-day period required to
establish cells in culture. Mononuclear cells were washed with
cold PBS and overlaid with fresh DME containing 0.5 Ci of
fatty acid (14C-linoleic acid, '4C-dihomogammalinolenic acid, or
14C-arachadonic acid). Cells were reincubated for defined time
periods under 5% C02/95% air at 37°C. At the appropriate time
a 0.2-ml aliquot of supernatant was removed for radioactivity
determination. Cell monolayers were then washed and lysed
with freshly prepared 0.05% Triton X-l00, after which they
were assayed for radioactivity. Percentage uptake per 100 g
cell protein is expressed relative to a baseline radioactivity
determination from original fatty acid/DME solutions.
Results
Cell recovery
The total cell recovery was comparable from CAPD patients
and healthy volunteers, approximating 8.5 million cells, about
90% of which were viable, and 86.5 and 93.2%, respectively, of
which were mononuclear phagocytes by nonspecific esterase
staining. Total peripheral blood leukocyte and monocyte counts
were similar between patients and controls (Table 2). Those
patients with peritoneal eosinophilia, most commonly observed
during the first 21 to 35 days following surgical placement of a
new dialysis catheter, were excluded from the study.
The total protein content of dialysis supernatants was rou-
tinely measured. These measurements (N = 32) averaged 1.35
0.09 mglml, representing a protein loss of 2 to 3 g per
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Table 2. Comparison of peritoneal and peripheral blood leukocyte
populations
Cell characteristics
CAPD patients(N = 20)
Healthy volunteers(N = 5)
Peritoneal
Yield (106 cells) 8.6 8.5
Viability 89% 92%
Differential
Mononuclear cells
Esterase positive 86.5% 93.2%
Esterase negative 7.2% 6.8%
Neutrophils 3.4% 0.0%
Eosinophils 2.9% 0.0%
Peripheral blood
Leukocytes (per mm3) 7303 7800
Monocytes (%) 4.4 4.0
Absolute monocyte count
(per mm3) 284 312
exchange. We also routinely measured the dialysate super-
natant osmolality, glucose, and urea concentration for the first
20 patients studied; in all patients we found that these param-
eters had equilibrated with coincident serum values.
Morphology
Peritoneal cells from healthy volunteers showed morphologic
characteristics of monocyte-macrophages and the population
was uniform (Fig. 1A). Cytoplasmic vacuoles were commonly
seen, as has been previously reported [15]. Peritoneal mono-
nuclear cells from CAPD patients had morphologic features of
mononuclear phagocytes but displayed some structural hetero-
geneity with respect to cell size, intensity of nuclear and
cytoplasmic staining, and variability of cytoplasmic esterase
activity (Fig. 1B). The ultrastructural features of peritoneal
mononuclear cells from patients and controls were similar to
peripheral blood monocytes with respect to nuclear morphol-
ogy, organelle content, and membrane contour.
Surface markers
Immunoglobulin Fc receptors were present on peritoneal
monocytes, which generally bound greater than 12 erythrocytes
per monocyte. When the incubation period of the rosetting
assay was extended beyond 2 hr, erythrocyte phagocytosis was
easily demonstrated. Peritoneal monocytes from healthy volun-
teers and CAPD patients, and peripheral blood monocytes from
healthy volunteers and CAPD patients expressed DR antigen
(Table 3). Greater than 75% of each cell suspension was DR+
by immunofluorescence, a feature of monocytes [29].
Monocyte maturation in culture
Peritoneal monocytes from CAPD patients which were estab-
lished in long-term monolayer culture followed a recognized
morphologic sequence of events [23]. Cells became adherent to
the culture well within hours. By 24 hr these cells exhibited
extensive aggregation. Beginning at 48 hr the cells dispersed,
developed a slightly oval shape, and became intensely esterase
positive. After approximately 7 days the cells were completely
dispersed and had a fibroblastoid morphology; cytoplasmic
esterase activity was decreased. Peritoneal monocytes from
Fig. 1. Mononuclear phagocyte morphology. A Peritoneal macro-
phages, healthy volunteer (PMC-N). These cells have uniform size and
staining characteristics. Cytoplasmic vacuoles are present in several
cells. (Cytospin preparation, Wright-Giemsa stain, x 540) B Peritoneal
macrophages, CAPD patient (PMC-CAPD). These cells have remark-
able variability in cell size and staining intensity. (Cytospin preparation,
Wright-Giemsa stain, x 580)
Table 3. HLA-DR antigen expression by peritoneal and peripheral
blood mononuclear phagocytes from CAPD patients and healthy
volunteers
Cell source N
Esterase +
%
DR+
%
PMC-N 4 93.2 91
PMC-CAPD 14 86.5 75
PBM-N 3 97.0 86
PBM-CAPD 4 96.0 74
Abbreviations: PMC-CAPD, peritoneal monocytes from CAPD pa-
tient dialysate; PBM-CAPD, peripheral blood monocytes from CAPD
patient; PMC-N, peritoneal monocytes from laparoscopy aspirate from
healthy volunteers; PBM-N, peripheral blood monocytes from healthy
volunteers.
healthy volunteers underwent similar morphologic changes
(Fig. 2).
Human peripheral blood monocytes do not contain the
membrane-bound enzyme ecto-S'nucleotidase (5'NT), but
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Table 5. Hydrogen peroxide generation by peripheral blood
monocytes and peritoneal macrophages from CAPD patients and
healthy volunteers in response to stimulation with phorbol ester
H202,
Cell source N
nm H202/10 ceus/JO mm
0 PMA 100 nM PMA
PMN 3 0.06 0.01 6.30 0.40
PBM-N 5 0.01 0.00 1.40 0.20
PMC-N 3 0.02 0.00 1.70 0.50
PMC-CAPD 4 0.00 0.00 1.50 0.20
PMC-CAPD (24 hr) 3 0.00 0.00 2.00 0.20
Abbreviations: PMN, peripheral blood granulocytes from healthy
volunteers; also see Table 3.
Fig. 2. Macrophage evolution in monolayer culture. Peritoneal macro-
phages from normal volunteers, 3-day culture (phase contrast). Cells
are separated, and some cells have begun to elongate. Peritoneal
macrophages from CAPD patients follow the same pattern of evolution,
along the same time course. (Final magnification, x 200)
Table 4. Ecto-S'nucleotidase activity of freshly isolated and cultured
peripheral blood m000cytes and peritoneal macrophages
5' Nucleotidase
Cell source N nm 5'AMP hydrolyzed/mm/mg protein
Freshly isolated
PBM-N 3 0.00 0.00
PMC-N 5 0.15 0.14
PMC-CAPD 8 0.69 0.22
72—96 hr culture
PBM-N 2 19.78 1.78
PMC-N 3 21.46 3.44
PBM-CAPD 3 19.16 2.20
See Table 3 for explanation of abbreviations.
when allowed to differentiate into macrophages, they accumu-
late large quantities of the enzyme [301. Peripheral blood
monocytes from healthy volunteers had no detectable 5'NT by
our assay, which was expected. However, neither peritoneal
cells from CAPD patients nor from healthy volunteers con-
tained significant quantities. We studied all cell populations
studied, allowed them to differentiate into macrophages in vitro
over 72 hr on glass cover slips, and found they produced large
amounts of 5'NT (Table 4).
Hydrogen peroxide production
Human peripheral blood monocytes and peritoneal macro-
phages have previously been shown to be capable of equivalent
hydrogen peroxide generation in response to PMA [31]. We
compared the ability of cells from CAPD patients and cells from
healthy control subjects to generate toxic oxygen metabolites
by measuring the amount of hydrogen peroxide produced in
response to membrane stimulation with phorbol esters. Periph-
eral blood polymorphonuclear leukocytes and monocytes ob-
tained from healthy volunteers serve as reference standards. It
is widely accepted that monocytes produce only 20 to 25% as
much peroxide as granulocytes [321. In these experiments, that
Table 6. Bactericidal activity of peritoneal macrophages and
peripheral blood monocytes from CAPD patients and healthy
volunteers using pooled normal human sera as an opsonin source
Cell source N
% Killing
Staphylococcus aureus Escherichia coli
PBM-N
PBM-CAPD
PMC-N
PMC-CAPD
5
4
4
6
76.0 2.6
70.5 3.3
68.3 1.0
72.2 2.5
67.2
66.0
67.0
71.5
2.5
4.9
2.7
3.6
See Table 3 for explanation of abbreviations.
finding is confirmed and all peripheral blood monocytes and
peritoneal macrophage cell populations produced similar
amounts of hydrogen peroxide (Table 5).
Bactericidal activity
Hypotonic lysates of peritoneal cells from CAPD patients
failed to yield recoverable bacteria when cultured (data not
shown), Bactericidal activity for Staphylococcus aureus and
Escherichia coli by peripheral blood and peritoneal mono-
nuclear cells from both CAPD patients and healthy controls was
similar (Table 6), using pooled normal human serum as an
opsonin source.
Chemot axis
The chemotactic behavior of peripheral blood and peritoneal
mononuclear cells in response to a complement-independent
chemoattractant, the synthetic oligopeptide FMLP was also
studied. Peripheral blood monocytes from normal controls
averaged a score of 42.8%, similar to other studies using this
technique [281. The mean chemotaxis score of peripheral blood
monocytes from CAPD patients is significantly higher (P <
0.001). A significant difference (P < 0.05) is also seen in the
performance of corresponding peritoneal cells, where macro-
phages of CAPD patients score above healthy volunteers.
Peripheral blood monocytes from hemodialysis patients, how-
ever, behaved similarly to normal control subjects' peripheral
blood monocytes, with a chemotaxis score of 42.3% (Table 7).
Eicosanoid precursor uptake
Cells from CAPD patients and healthy volunteers exhibited a
significant difference in uptake of eicosanoid precursors (Table
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Table 7. Chemotaxis of mononuclear phagocytes from CAPD patients
and healthy volunteers
Cell source N
Chemotaxis
maximum % migration/hr
PBM-N
PBM-CAPD
PBM-HD
20
8
5
42.8 1.3
63.5 4.1 P < 0.001
42.3 1.4
PMC-N
PMC-CAPD
6
11
3.0 0.5
11.5 3.0 P < 0.05
PMC-N (24 hr)
PMC-CAPD (24 hr)
4
11
1.5 0.2
13.9 2.5 P < 0.02
Abbreviations: PBM-HD, peripheral blood monocytes from patients
undergoing maintenance hemodialysis; also see Table 3.
Table 8. Uptake of eicosanoid precursors by peripheral blood
monocytes and peritoneal macrophages (5-day culture) from CAPD
patients and healthy volunteers
Precursor (N)
Uptake,
% per 100 j.g
cell protein P
Linoleic acid
PBM-N (7)
PBM-CAPD (6)
PBM-HD (7)
PMC-N (5)
PMC-CAPD (7)
35.7 11.8
15.7 1.7
22.8 2.9
126.0 7.9
79.9 15.2 <0.02
Dihomogammalinolenic acid
PBM-N (7)
PBM-CAPD (6)
PBM-HD (7)
PMC-N (5)
PMC-CAPD (7)
58.7 9.3
17.5 1.3
34.8 5.0
149.5 52
82.5 6.8
<0.02
<0.01
Arachidonic acid
PBM-N (7)
PBM-CAPD (6)
PBM-HD (7)
PMC-N (5)
PMC-CAPD (7)
56.4 4.0
10.3 0.9
34.3 5.7
121.9 8.7
93.8 14.9
<0.001
See Table 3 for explanation of abbreviations.
8). For each precursor studied, uptake by peripheral blood and
peritoneal cells from CAPD patients was significantly less than
that of corresponding cells from healthy volunteers at the same
time point (P < 0.02). Precursor uptake by peripheral blood
monocytes from CAPD patients increased with time in culture
(7.day cultures: 35.9% 3.1% for linoleic acid, 46.2% 3.1%
for dihomogammalinolenic acid and 27.8% 0.9% for
arachadonic acid; P < 0.005 compared to 5-day culture data
presented in Table 8). Peripheral blood monocytes from
hemodialysis patients had an intermediate uptake of
dihomogammalinolenic acid and arachadonic acid; the cells
were remarkably closer to those from healthy volunteers.
Discussion
We explored the possibility that mononuclear phagocytes
play a role in peritoneal host defense in patients undergoing
CAPD by characterizing the structure and function of these
cells from peritoneal fluid and peripheral blood. These experi-
ments sought to identify functional defects which might impair
local antibacterial activity in some patients, and examine the
effect of the dialysis procedure on the composition of the
resident peritoneal mononuclear phagocyte population.
The presence of HLA-DR antigen on the surface of a majority
of peritoneal cells from CAPD patients supports the contention
that they are mononuclear phagocytes [29]. Although it has
been reported that all peripheral blood monocytes from healthy
volunteers and peritoneal monocytes from patients undergoing
CAPD express Ia-like antigens on their surface [33], the tech-
nique of immunofluorescent microscopy which we used does
not detect very small quantities of Ia-like antigen.
Furthermore, our data indicate that these cells have mor-
phologic characteristics of resting, not stimulated, mononuclear
phagocytes based on the lack of membrane ruffling and charac-
teristic organelle content. This suggests that dialysate has no
activating effect on these mononuclear phagocytes. Alterna-
tively, those cells which survive and are recovered by our
procedure may have entered the peritoneum only after the 3 hr
required for pH and osmotic equilibration between dialysate
and extracellular fluid. The results obtained when we attempted
to study the effects of fresh dialysate in vitro support this latter
possibility. Without exception, all mononuclear cells (periph-
eral blood or peritoneal) which were incubated in 100, 50, or
25% fresh dialysate (pH 5.5, osmolality 310 to 580 mOsm/kg)
with or without 20% MS showed complete loss of viability
within 30 mm (data not shown). Adjusting the pH to 7.4 did not
alter this loss of viability. Perhaps cells which are present in the
peritoneum when fresh dialysate is introduced are killed, or
local protective elements may exist in vivo which did not exist
in this in vitro system. The increased morphologic and esterase
stain heterogeneity among peritoneal monocytes from CAPD
patients is consistent with the interpretation that there is
accelerated repopulation of the peritoneum by these cells,
possibly after the noxious influence of acidity and hypertonicity
resolve during the period of the exchange.
In addition to morphologic and staining characteristics, ab-
sence of ecto-S'nucleotidase (5'NT) suggests that these pen-
toneal cells are blood-derived monocytes, not yet differentiated
into macrophages. Peripheral blood monocytes in humans lack
detectable quantities of this enzyme [30]. Monocytes which
mature into macrophages, either in vivo or in vitro, accumulate
large amounts of 5'NT. If activated or stimulated, the macro-
phages will release the enzyme, leaving undetectable quantities
in cell lysates. Parwaresch, Radzun, and Sommes [341 have
provided data that support the monocyte origin of peritoneal
macrophages; namely the similar isoelectric focusing patterns
of acid esterase in human peripheral blood monocytes and
penitoneal macrophages.
The peritoneal mononuclear cells from CAPD patients fol-
lowed a maturational pathway which has been described for
peripheral blood monocytes from healthy persons. This applies
to their morphological evolution in long-term culture [23], as
well as the development of membrane enzyme systems which
customarily accompany differentiation from monocyte to
macrophage [301.
We also observed that peritoneal and peripheral blood
monocytes from CAPD patients have higher chemotaxis scores
than control cells or cells from hemodialysis patients. The
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reasons for this are not completely clear, but it is doubtful that
persistent subclinical infection is the cause. The release of
phlogistic products into the dialysate would lead to a uniform
distribution of chemoattractant, not a gradient. These condi-
tions should deactivate the monocytes, leading to decreased
chemotaxis toward that attractant in vitro, but not affecting the
cellular response to chemically unrelated chemoattractants
[35]. Furthermore, we were unable to identify evidence of
indolent infection, as assessed by bacterial cultures of pen-
toneal macrophage lysates. An alternative hypothesis is that the
dialysate interacts with the peritoneum in a fashion which
generates substances capable of increasing the chemotactic
activity of peritoneal monocytes. Although it has been shown
that under carefully structured conditions, antigenic challenge
of the rodent peritoneum leads to the generation of a lipid
chemotactic factor(s) [36], the argument of deactivation by
exposure to a uniform concentration of a specific attractant
applies. Nevertheless, even if such factor(s) were generated,
the response to the synthetic oligopeptide which we used in our
in vitro chemotaxis assay system should be unaffected by
previous exposure to a chemically unrelated stimulant [37]. It is
possible, however, that the increased chemotactic activity may
be related to a relative immaturity of cells from CAPD patients.
The continuous removal of 30 to 40 million peritoneal
monocytes daily may stimulate bone marrow replacement of
resident cells at an excessive rate. Alteri and Leonard [38] have
shown that the chemotaxis of young mononuclear cells which
repopulate the peripheral circulation 3 hr following leuka-
pheresis are more active in chemotaxis than are the older cells
which remain immediately following the apheresis procedure.
Selective repopulation by a younger, more motile subpopula-
tion of marrow-derived monocytes is proposed.
We further attempted to assess the degree of maturation of
the mononuclear phagocytes from CAPD patients by examining
the uptake of eicosanoid precursors. The incorporation of these
fatty acid precursors appears to increase with cell maturity [39,
40]. The difference in incorporation which we observed favors
the argument that peritoneal cells from CAPD patients are
younger than peritoneal cells from healthy volunteers. The
absolute values obtained for mononuclear phagocytes from
CAPD patients demonstrate that these cells also have the
capability for precursor uptake.
Among our CAPD population there are patients whose
peritonitis incidence is extremely high, some exceeding twelve
episodes annually; whereas peritonitis has never developed in
other patients during 27 months of therapy. This variability
appears to be independent from technical considerations or
aspects of personal hygiene. We did not identify a relationship
between individual chemotaxis scores and incidence of
peritonitis among our patients. Factors such as dialysate fibrin
content, nutritional status [41, 42], serosal bleeding, and cath-
eter tunnel wound strength may be confounding influences.
Other monocyte functions, for example, T lymphocyte inter-
actions or the elaboration of opsonin, may be altered in some
patients due to an inadequate supply of mature macrophages
[43, 441. We believe, based on increased chemotaxis activity
and a lower percentage of eicosanoid precursor uptake by
peritoneal macrophages from CAPD patients, that these cells
are relatively immature monocytes, freshly derived from bone
marrow. Further experiments are required to analyze additional
factors which may differentiate susceptibility to peritoaitis
among these patients.
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